Motilal Oswal Recommends Buying Symbiotec Pharmalab, Sets Rs 1,430 Target
Motilal Oswal’s research report recommends buying Symbiotec Pharmalab and sets a target of Rs 1,430.
Motilal Oswal’s research report recommends buying Symbiotec Pharmalab and sets a target of Rs 1,430.